Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in AJNR Am J Neuroradiol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    September 2017
  1. ROGERS DM, Peckham ME, Shah LM, Wiggins RH 3rd, et al
    Association of Developmental Venous Anomalies with Demyelinating Lesions in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Sep 14. doi: 10.3174/ajnr.A5374.
    PubMed     Text format     Abstract available


    August 2017
  2. HAGIWARA A, Hori M, Yokoyama K, Nakazawa M, et al
    Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio.
    AJNR Am J Neuroradiol. 2017 Aug 3. doi: 10.3174/ajnr.A5312.
    PubMed     Text format     Abstract available


    July 2017
  3. EICHINGER P, Kirschke JS, Hoshi MM, Zimmer C, et al
    Pre- and Postcontrast 3D Double Inversion Recovery Sequence in Multiple Sclerosis: A Simple and Effective MR Imaging Protocol.
    AJNR Am J Neuroradiol. 2017 Jul 27. doi: 10.3174/ajnr.A5329.
    PubMed     Text format     Abstract available


    June 2017
  4. SARTORETTI T, Sartoretti E, Rauch S, Binkert C, et al
    How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis?
    AJNR Am J Neuroradiol. 2017 Jun 29. doi: 10.3174/ajnr.A5262.
    PubMed     Text format     Abstract available


  5. SHINOHARA RT, Oh J, Nair G, Calabresi PA, et al
    Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Jun 22. doi: 10.3174/ajnr.A5254.
    PubMed     Text format     Abstract available


  6. ROVIRA A, Auger C, Huerga E, Corral JF, et al
    Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Jun 15. doi: 10.3174/ajnr.A5253.
    PubMed     Text format     Abstract available


  7. SPAMPINATO MV, Kocher MR, Jensen JH, Helpern JA, et al
    Diffusional Kurtosis Imaging of the Corticospinal Tract in Multiple Sclerosis: Association with Neurologic Disability.
    AJNR Am J Neuroradiol. 2017 Jun 1. doi: 10.3174/ajnr.A5225.
    PubMed     Text format     Abstract available


    May 2017
  8. SETHI SK, Daugherty AM, Gadda G, Utriainen DT, et al
    Jugular Anomalies in Multiple Sclerosis Are Associated with Increased Collateral Venous Flow.
    AJNR Am J Neuroradiol. 2017 May 25. doi: 10.3174/ajnr.A5219.
    PubMed     Text format     Abstract available


  9. GUPTA A, Al-Dasuqi K, Xia F, Askin G, et al
    The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2017 May 18. doi: 10.3174/ajnr.A5209.
    PubMed     Text format     Abstract available


  10. FORSLIN Y, Shams S, Hashim F, Aspelin P, et al
    Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
    AJNR Am J Neuroradiol. 2017 May 11. doi: 10.3174/ajnr.A5211.
    PubMed     Text format     Abstract available


  11. WANG W, van Heerden J, Tacey MA, Gaillard F, et al
    Neuroradiologists Compared with Non-Neuroradiologists in the Detection of New Multiple Sclerosis Plaques.
    AJNR Am J Neuroradiol. 2017 May 4. doi: 10.3174/ajnr.A5185.
    PubMed     Text format     Abstract available


    April 2017
  12. BURGETOVA A, Dusek P, Vaneckova M, Horakova D, et al
    Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Apr 27. doi: 10.3174/ajnr.A5166.
    PubMed     Text format     Abstract available


  13. MCNAMARA C, Sugrue G, Murray B, MacMahon PJ, et al
    Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.
    AJNR Am J Neuroradiol. 2017 Apr 20. doi: 10.3174/ajnr.A5148.
    PubMed     Text format     Abstract available


  14. CASTELLARO M, Magliozzi R, Palombit A, Pitteri M, et al
    Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Apr 13. doi: 10.3174/ajnr.A5150.
    PubMed     Text format     Abstract available


  15. MCNAMARA C, Sugrue G, Murray B, MacMahon PJ, et al
    Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.
    AJNR Am J Neuroradiol. 2017 Apr 13. doi: 10.3174/ajnr.A5147.
    PubMed     Text format     Abstract available


    February 2017
  16. FUJIWARA E, Kmech JA, Cobzas D, Sun H, et al
    Cognitive Implications of Deep Gray Matter Iron in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2017 Feb 23. doi: 10.3174/ajnr.A5109.
    PubMed     Text format     Abstract available


    December 2016
  17. HAGIWARA A, Hori M, Yokoyama K, Takemura MY, et al
    Synthetic MRI in the Detection of Multiple Sclerosis Plaques.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  18. VIDAL-JORDANA A, Pareto D, Sastre-Garriga J, Auger C, et al
    Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  19. THALER C, Faizy TD, Sedlacik J, Holst B, et al
    T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016 Nov 10. doi: 10.3174/ajnr.A5004.
    PubMed     Text format     Abstract available


    October 2016
  20. HAGIWARA A, Hori M, Yokoyama K, Takemura MY, et al
    Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  21. PAKPOOR J, Saylor D, Izbudak I, Liu L, et al
    Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  22. D'ORTENZIO RM, Hojjat SP, Vitorino R, Cantrell CG, et al
    Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  23. TRABOULSEE A, Li D
    Addressing Concerns Regarding the Use of Gadolinium in a Standardized MRI Protocol for the Diagnosis and Follow-Up of Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format    


    July 2016
  24. STORELLI L, Pagani E, Rocca MA, Horsfield MA, et al
    A Semiautomatic Method for Multiple Sclerosis Lesion Segmentation on Dual-Echo MR Imaging: Application in a Multicenter Context.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  25. ZHANG Y, Gauthier SA, Gupta A, Tu L, et al
    Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  26. CABEZAS M, Corral JF, Oliver A, Diez Y, et al
    Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  27. BIAN W, Tranvinh E, Tourdias T, Han M, et al
    In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  28. ZHANG Y, Gauthier SA, Gupta A, Chen W, et al
    Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  29. VITORINO R, Hojjat SP, Cantrell CG, Feinstein A, et al
    Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  30. SUNDARAKUMAR DK, Smith CM, Hwang WD, Mossa-Basha M, et al
    Evaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. HOJJAT SP, Kincal M, Vitorino R, Cantrell CG, et al
    Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  32. CHAWLA S, Kister I, Wuerfel J, Brisset JC, et al
    Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  33. WIEBENGA OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, et al
    White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  34. HARRISON DM, Li X, Liu H, Jones CK, et al
    Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  35. ZIVADINOV R, Raj B, Ramanathan M, Teter B, et al
    Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  36. WIGGERMANN V, Hernandez-Torres E, Traboulsee A, Li DK, et al
    FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection.
    AJNR Am J Neuroradiol. 2016;37:259-65.
    PubMed     Text format     Abstract available


    January 2016
  37. GRANBERG T, Uppman M, Hashim F, Cananau C, et al
    Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


  38. GALLER S, Stellmann JP, Young KL, Kutzner D, et al
    Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  39. LIU Y, Lukas C, Steenwijk M, Daams M, et al
    Multicenter Validation of Mean Upper Cervical Cord Area Measurements from Head 3D T1-Weighted MR Imaging in Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  40. SCHMALBROCK P, Prakash RS, Schirda B, Janssen A, et al
    Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


  41. TRABOULSEE A, Simon JH, Stone L, Fisher E, et al
    Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  42. BLYSTAD I, Hakansson I, Tisell A, Ernerudh J, et al
    Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


  43. PARETO D, Sastre-Garriga J, Auger C, Vives-Gilabert Y, et al
    Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


  44. CHONG AL, Chandra RV, Chuah KC, Roberts EL, et al
    Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  45. JONKMAN LE, Klaver R, Fleysher L, Inglese M, et al
    Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  46. VAN HEERDEN J, Rawlinson D, Zhang AM, Chakravorty R, et al
    Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
    AJNR Am J Neuroradiol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  47. CROMBE A, Saranathan M, Ruet A, Durieux M, et al
    MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3T.
    AJNR Am J Neuroradiol. 2015;36:501-7.
    PubMed     Text format     Abstract available


  48. ODENTHAL C, Coulthard A
    The prognostic utility of MRI in clinically isolated syndrome: a literature review.
    AJNR Am J Neuroradiol. 2015;36:425-31.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: